This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aemetis (AMTX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -17.14% and -35.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -20.51% and 22.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of 19.15% and 4.70%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -13.79% and 11.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -34.88% and 7.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should Constellation (CEG) Be in Your Portfolio Before Q1 Earnings?
by Zacks Equity Research
Constellation Energy's (CEG) first-quarter earnings are likely to have gained from strong demand from its C&I customers.
Aemetis (AMTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Aemetis (AMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aemetis (AMTX) Soars 39.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Aemetis (AMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sunrun (RUN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunrun's (RUN) Q4 results are likely to reflect the impact of a decline in its year-over-year solar energy capacity installed in California and higher interest expenses.
SolarEdge (SEDG) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
SolarEdge's (SEDG) Q4 results are likely to reflect the negative impacts of slow market demand and higher operating expenses.
Exxon Mobil (XOM) Q3 Earnings Lag Estimates
by Zacks Equity Research
Exxon (XOM) delivered earnings and revenue surprises of -3.81% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -142.86% and 32.97%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for July 27th
by Zacks Equity Research
AMTX, AROW and BHP have been added to the Zacks Rank #5 (Strong Sell) List on July 27, 2023.
New Strong Sell Stocks for July 21th
by Zacks Equity Research
AMTX, BHB and BNL have been added to the Zacks Rank #5 (Strong Sell) List on July 21, 2023.
New Strong Sell Stocks for July 18th
by Zacks Equity Research
AMTX, AU and BP have been added to the Zacks Rank #5 (Strong Sell) List on July 18, 2023.
Aemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -151.72% and 96.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -85.29% and 10.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earthstone Energy (ESTE) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Earthstone Energy (ESTE) delivered earnings and revenue surprises of 9.47% and 1.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aemetis (AMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Fortress Energy (NFE) Q4 Earnings Beat Estimates
by Zacks Equity Research
New Fortress Energy (NFE) delivered earnings and revenue surprises of 19.18% and 31.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for First Solar (FSLR) in Q4 Earnings?
by Zacks Equity Research
First Solar's (FSLR) Q4 results are likely to reflect the strong demand for products and solid bookings, along with the negative impact of higher costs on earnings.
Occidental Petroleum (OXY) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Occidental's (OXY) fourth-quarter earnings are likely to have gained from strong production from the Gulf of Mexico and Rockies region. Share repurchases and debt reduction would also boost earnings.
Sunrun (RUN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunrun's (RUN) Q4 results are likely to reflect a strong top line, buoyed by strength in the installation volume and a growing customer base.
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -15% and 9%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
How Much Upside is Left in Aemetis (AMTX)? Wall Street Analysts Think 210%
by Zacks Equity Research
The mean of analysts' price targets for Aemetis (AMTX) points to a 210% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.